Canada - English - Health Canada

mint pharmaceuticals inc - timolol (timolol maleate); latanoprost - solution - 5mg; 50mcg - timolol (timolol maleate) 5mg; latanoprost 50mcg - beta-adrenergic agents

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - latanoprost, quantity: 0.05 mg/ml; timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml) - eye drops, solution - excipient ingredients: hydrochloric acid; water for injections; sodium chloride; dibasic sodium phosphate; sodium hydroxide; benzalkonium chloride; monobasic sodium phosphate monohydrate - the reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. xalacom should not be used to initiate therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); latanoprost, quantity: 0.05 mg/ml - eye drops, solution - excipient ingredients: purified water; benzalkonium chloride; dibasic sodium phosphate dodecahydrate; sodium hydroxide; monobasic sodium phosphate dihydrate; hydrochloric acid; sodium chloride - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol (50 microgram/ml/5 mg/ml) eye drops should not be used to initiate therapy.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - timolol maleate 6,83 mg/ml - eq. timolol 5 mg/ml; latanoprost 0,05 mg/ml - eye drops, solution - 50 µg/ml - 5 mg/ml - latanoprost 0.05 mg/ml; timolol maleate 6.83 mg/ml - timolol, combinations

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - latanoprost 0.05 mg/ml; timolol maleate 6.83 mg/ml equivalent to 5 mg/ml timolol - eye drops, solution - active: latanoprost 0.05 mg/ml timolol maleate 6.83 mg/ml equivalent to 5 mg/ml timolol excipient: benzalkonium chloride dibasic sodium phosphate hydrochloric acid monobasic sodium phosphate dihydrate sodium chloride sodium hydroxide water for injection - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol sandoz 50/5 should not be used to initiate therapy.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aurobindo sa-nv - timolol maleate 6,83 mg/ml - eq. timolol 5 mg/ml; latanoprost 0,05 mg/ml - eye drops, solution - 0,005 % - 0,5 % - timolol maleate 6.83 mg/ml; latanoprost 0.05 mg/ml - timolol, combinations

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - latanoprost, quantity: 50 microgram/ml; timolol maleate, quantity: 5 mg/ml - eye drops, solution - excipient ingredients: monobasic sodium phosphate monohydrate; benzalkonium chloride; water for injections; dibasic sodium phosphate; hydrochloric acid; sodium chloride; sodium hydroxide - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol eye drops should not be used to initiate therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - latanoprost, quantity: 0.05 mg/ml; timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml) - eye drops, solution - excipient ingredients: sodium hydroxide; dibasic sodium phosphate dodecahydrate; purified water; benzalkonium chloride; hydrochloric acid; monobasic sodium phosphate dihydrate; sodium chloride - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol (50 microgram/ml/5 mg/ml) eye drops should not be used to initiate therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - latanoprost, quantity: 0.05 mg/ml; timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml) - eye drops, solution - excipient ingredients: purified water; sodium hydroxide; dibasic sodium phosphate dodecahydrate; benzalkonium chloride; monobasic sodium phosphate dihydrate; sodium chloride; hydrochloric acid - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol (50 microgram/ml/5 mg/ml) eye drops should not be used to initiate therapy.

Ireland - English - HPRA (Health Products Regulatory Authority)

generics (uk) limited - latanoprost, timolol - eye drops solution - 50mcg/ml + 5 mg/ml - beta blocking agents